Novel Drug Delivery Systems Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Novel Drug Delivery Systems. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Novel Drug Delivery Systems Indian Medical PG Question 1: Ocular effects that include mydriasis are characteristic of which of the following drugs?
- A. phenylephrine (alpha agonist) (Correct Answer)
- B. neostigmine (cholinesterase inhibitor)
- C. phentolamine (alpha blocker)
- D. mecamylamine (ganglionic blocker)
Novel Drug Delivery Systems Explanation: ***phenylephrine (alpha agonist)***
- **Phenylephrine** is a direct-acting **alpha-1 adrenergic agonist** that causes contraction of the **pupillary dilator muscle**, leading to **mydriasis** (pupil dilation). [1]
- It is frequently used clinically to dilate pupils for **ophthalmologic examinations** due to its selective action on alpha-1 receptors in the eye. [2]
*neostigmine (cholinesterase inhibitor)*
- **Neostigmine** inhibits acetylcholinesterase, increasing acetylcholine at the neuromuscular junction and muscarinic receptors. This leads to **miosis** (pupil constriction), not mydriasis.
- Its ophthalmic use is primarily for treating **glaucoma** by improving aqueous humor outflow through cholinergic effects on the ciliary muscle.
*phentolamine (alpha blocker)*
- **Phentolamine** is a **non-selective alpha-adrenergic antagonist** that blocks both alpha-1 and alpha-2 receptors.
- Alpha-1 receptor blockade in the eye would relax the pupillary dilator muscle, leading to **miosis** or prevention of mydriasis, not its induction.
*mecamylamine (ganglionic blocker)*
- **Mecamylamine** is a **ganglionic blocker** that antagonizes nicotinic receptors in both sympathetic and parasympathetic ganglia.
- Blocking parasympathetic ganglia can cause some mydriasis, but ganglionic blockers have widespread, non-selective autonomic effects and are not primarily used for isolated mydriasis.
Novel Drug Delivery Systems Indian Medical PG Question 2: Which route is most preferred for Endophthalmitis treatment?
- A. Oral antibiotic
- B. Intravenous antibiotic
- C. Topical antibiotic
- D. Intravitreal antibiotic (Correct Answer)
Novel Drug Delivery Systems Explanation: ***Intravitreal antibiotic***
- **Intravitreal injection** directly delivers a high concentration of antibiotics into the **vitreous cavity**, which is essential for treating intraocular infections like endophthalmitis.
- This route bypasses protective barriers like the **blood-retinal barrier**, ensuring therapeutic drug levels reach the infection site promptly and effectively.
*Oral antibiotic*
- **Oral antibiotics** have poor penetration into the **vitreous humor** due to the **blood-retinal barrier**, making them generally ineffective as a sole therapy for endophthalmitis.
- They may be used as an adjunct in some cases but cannot achieve the high local concentrations needed to resolve severe intraocular infections.
*Intravenous antibiotic*
- Similar to oral antibiotics, **intravenous antibiotics** struggle to penetrate the **blood-retinal barrier** adequately to achieve therapeutic concentrations in the vitreous humor for endophthalmitis.
- While they can be administered in severe cases, they do not provide the direct, high-dose delivery needed to control the infection within the eye as effectively as intravitreal injections.
*Topical antibiotic*
- **Topical antibiotics** primarily reach the ocular surface and anterior segment of the eye, with very limited penetration into the **vitreous cavity**.
- They are generally ineffective for treating endophthalmitis, which is an infection of the inner eye, and are typically reserved for superficial ocular infections.
Novel Drug Delivery Systems Indian Medical PG Question 3: Which of the following drugs should be given in a sustained-release oral dosage form?
- A. An anti-arrhythmic drug with a plasma half life of 10 seconds used for acute treatment of PSVT
- B. Anti inflammatory drugs with the plasma half life of 24 hours
- C. Hypnotic drugs with a plasma half life of 2 hours
- D. An antihypertensive with a plasma half-life of 3 hours (Correct Answer)
Novel Drug Delivery Systems Explanation: *An anti-arrhythmic drug with a plasma half life of 10 seconds used for acute treatment of PSVT*
- An extremely short **half-life** (10 seconds) indicates a drug suitable for **rapid-onset, acute interventions**, where the effect is needed immediately and for a very brief duration, making sustained release impractical.
- Drugs like **adenosine**, used for acute PSVT, are given intravenously as a rapid bolus due to their ultra-short half-life, not in an oral sustained-release form.
*Anti inflammatory drugs with the plasma half life of 24 hours*
- A long **half-life** (24 hours) typically means the drug can be administered **once daily** to maintain therapeutic concentrations, rendering a sustained-release formulation unnecessary.
- Such drugs already provide **prolonged action** and do not benefit significantly from further extension of release.
*Hypnotic drugs with a plasma half life of 2 hours*
- While a 2-hour half-life for a hypnotic might suggest potential for sustained release to prolong sleep, the goal of hypnotics is often a **rapid onset and relatively short duration** to avoid hangover effects.
- Sustained release might cause **daytime sedation** and interfere with normal wakefulness, which is generally undesirable for this class of drugs.
***An antihypertensive with a plasma half-life of 3 hours***
- A short **half-life** (e.g., 3 hours) often necessitates frequent dosing to maintain therapeutic levels, making a **sustained-release formulation desirable** for patient compliance and consistent drug exposure.
- Sustained-release dosage forms are particularly useful for drugs requiring **long-term, stable plasma concentrations**, such as antihypertensives, to manage chronic conditions effectively.
Novel Drug Delivery Systems Indian Medical PG Question 4: Which of the following is an example of a prodrug?
- A. Primidone
- B. Digitoxin
- C. Amitriptyline
- D. Levodopa (Correct Answer)
Novel Drug Delivery Systems Explanation: ***Levodopa is a prodrug that converts to dopamine.***
- A **prodrug** is an inactive precursor of a drug that is converted into its active form within the body.
- **Levodopa** is converted to the active neurotransmitter **dopamine** in the brain, making it effective for Parkinson's disease.
*Primidone is an anticonvulsant with active metabolites.*
- While Primidone has **active metabolites** (phenobarbital and phenylethylmalonamide), the parent drug itself also possesses significant **anticonvulsant activity**, meaning it is not an inactive precursor.
- A true prodrug is therapeutically inactive until metabolized.
*Digitoxin is a cardiac glycoside that acts directly.*
- **Digitoxin** is a cardiac glycoside that directly inhibits the **Na+/K+-ATPase pump**, exerting its therapeutic effect without requiring conversion to an active metabolite.
- It does not undergo enzymatic conversion to an active form to produce its primary action.
*Amitriptyline is an antidepressant that acts directly.*
- **Amitriptyline** is a **tricyclic antidepressant** that directly inhibits the reuptake of norepinephrine and serotonin.
- While it is metabolized to an active metabolite (nortriptyline), Amitriptyline itself is **pharmacologically active** as the parent drug.
Novel Drug Delivery Systems Indian Medical PG Question 5: Cycloplegics are used for the treatment of:
- A. Lens-induced glaucoma
- B. Closed-angle glaucoma
- C. Iridocyclitis (Correct Answer)
- D. Chorioretinitis
Novel Drug Delivery Systems Explanation: ***Iridocyclitis***
- **Cycloplegics** paralyze the **ciliary muscle** and **iris sphincter**, reducing spasm and pain associated with inflammation in iridocyclitis.
- They also help prevent the formation of **posterior synechiae**, adhesions between the iris and the lens.
- This is the **primary therapeutic indication** for cycloplegics in inflammatory conditions.
*Lens-induced glaucoma*
- This condition is caused by **lens swelling** or **leakage of lens material**, leading to elevated intraocular pressure.
- Treatment typically involves **surgical removal of the cataractous lens**, not cycloplegics.
*Closed-angle glaucoma*
- Cycloplegics are **CONTRAINDICATED** in closed-angle glaucoma as they cause **pupillary dilation**, which can precipitate or worsen angle closure.
- The condition is characterized by **blockage of aqueous humor outflow** due to the iris obstructing the trabecular meshwork.
- Treatment involves methods to open the angle, such as **laser iridotomy** or medications that **constrict the pupil** (miotics) or reduce aqueous humor production.
*Chorioretinitis*
- This is an **inflammation of the choroid and retina**, layers located at the back of the eye (posterior segment).
- Treatment primarily involves **systemic anti-inflammatory agents** and antimicrobials if infectious.
- Cycloplegics do not directly address posterior segment inflammation, though they may be used for symptomatic relief if anterior chamber reaction is present.
Novel Drug Delivery Systems Indian Medical PG Question 6: In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?
- A. Procaine
- B. Cocaine
- C. Prilocaine (Correct Answer)
- D. Tetracaine
Novel Drug Delivery Systems Explanation: **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.**
***Prilocaine***
- **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**.
- It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**.
*Cocaine*
- **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**.
- Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**.
*Procaine*
- **Procaine** is a classic **ester-type local anesthetic** (an aminoester).
- An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification.
*Tetracaine*
- **Tetracaine** is also an **ester-type local anesthetic** (an aminoester).
- It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.
Novel Drug Delivery Systems Indian Medical PG Question 7: Which of the following drugs is not used in treatment of iridocyclitis:
- A. Pilocarpine eye drops
- B. Atropine eye ointment
- C. Steroid eye drops
- D. Timolol eye drops (Correct Answer)
Novel Drug Delivery Systems Explanation: ***Timolol eye drops***
- **Timolol** is a **beta-blocker** used to reduce intraocular pressure in **glaucoma** by decreasing aqueous humor production.
- It has **no role in iridocyclitis management** as it does not address inflammation, pain, or pupillary abnormalities, which are the key therapeutic targets.
- Timolol is simply not part of the treatment protocol for iridocyclitis.
*Pilocarpine eye drops*
- **Pilocarpine** is a **miotic** agent that constricts the pupil, but it is **contraindicated** in iridocyclitis (not just "not used").
- While not used therapeutically, it's important to distinguish that pilocarpine is actively harmful (increases inflammation and posterior synechiae risk), whereas timolol is simply not indicated.
- In the context of this question asking what is "not used in treatment," timolol is the better answer as it's not part of the standard treatment protocol.
*Atropine eye ointment*
- **Atropine** is a **cycloplegic and mydriatic** agent that is a **cornerstone of iridocyclitis treatment**.
- It dilates the pupil and paralyzes the ciliary muscle to prevent and break **posterior synechiae** and relieve pain from ciliary muscle spasm.
- By immobilizing the iris and ciliary body, it reduces inflammation and discomfort.
*Steroid eye drops*
- **Steroid eye drops** (e.g., prednisolone acetate) are **essential for managing iridocyclitis** as they effectively reduce inflammation within the anterior chamber.
- They suppress the immune response causing inflammation, thereby alleviating symptoms like redness, pain, and photophobia.
- Topical corticosteroids are the mainstay of anti-inflammatory treatment in anterior uveitis.
Novel Drug Delivery Systems Indian Medical PG Question 8: Surgery of choice for chronic acquired dacryocystitis
- A. Dacryocystorhinostomy (Correct Answer)
- B. Dacryocystectomy
- C. Conjunctivo-cystorhinostomy
- D. None of the options
Novel Drug Delivery Systems Explanation: ***Dacryocystorhinostomy***
- This procedure creates a new connection between the **lacrimal sac** and the **nasal cavity**, bypassing the obstructed nasolacrimal duct.
- It is the **surgery of choice** for chronic acquired dacryocystitis as it provides a permanent solution for tear drainage.
*Dacryocystectomy*
- This involves **excision of the lacrimal sac**, which can relieve symptoms of infection but eliminates the sac's function.
- It is generally reserved for cases where dacryocystorhinostomy is contraindicated or has failed, and is **not the primary choice** for restoring tear flow.
*Conjunctivo-cystorhinostomy*
- This procedure creates a bypass from the **conjunctiva** directly to the **nasal cavity**, typically used when the canaliculi are also obstructed.
- It is a more complex surgery indicated for **proximal lacrimal system obstruction** (e.g., canalicular block) rather than isolated nasolacrimal duct obstruction.
*None of the options*
- **Dacryocystorhinostomy** is the well-established and most effective surgical intervention for chronic acquired dacryocystitis.
- Therefore, this option is incorrect as there is a suitable surgical choice available.
Novel Drug Delivery Systems Indian Medical PG Question 9: Which of the following drugs possesses similar cycloplegic action and is a more potent mydriatic than atropine?
- A. Hyoscine (Correct Answer)
- B. Tropicamide
- C. Homatropine
- D. All of the above
Novel Drug Delivery Systems Explanation: **Explanation:**
The correct answer is **Hyoscine (Scopolamine)**.
**Why Hyoscine is the correct answer:**
Hyoscine is a belladonna alkaloid that acts as a competitive antagonist at muscarinic receptors. In terms of ocular potency, it is significantly more potent than atropine on a weight-for-weight basis. While it produces a **similar degree of cycloplegia** (paralysis of the ciliary muscle), it is a **more potent mydriatic** (pupillary dilator) than atropine. Its duration of action (3–7 days) is shorter than that of atropine (7–10 days), making it a useful alternative when a potent but slightly shorter-acting cycloplegic is required.
**Analysis of Incorrect Options:**
* **Tropicamide:** This is the shortest-acting mydriatic (duration 4–6 hours). While it is excellent for fundus examination, its cycloplegic action is much weaker and shorter than atropine.
* **Homatropine:** A semi-synthetic derivative that is 10 times less potent than atropine. It has a shorter duration of action (1–3 days) and is primarily used in the treatment of anterior uveitis to prevent synechiae without the prolonged blurriness of atropine.
**High-Yield Clinical Pearls for NEET-PG:**
* **Potency Order:** Hyoscine > Atropine > Homatropine.
* **Duration of Action (Cycloplegia):** Atropine (7–10 days) > Hyoscine (3–7 days) > Homatropine (1–3 days) > Cyclopentolate (24 hours) > Tropicamide (6 hours).
* **Drug of Choice:** Atropine is the drug of choice for refraction in children <5 years (due to strong accommodation), while Homatropine/Cyclopentolate is preferred for older children.
* **Side Effect:** Systemic absorption of atropine in children can lead to "Atropine flushing," fever, and tachycardia.
Novel Drug Delivery Systems Indian Medical PG Question 10: Pilocarpine is the drug of choice in which type of glaucoma?
- A. Open angle glaucoma
- B. Acute angle closure glaucoma (Correct Answer)
- C. Pigmentary glaucoma
- D. None of the above
Novel Drug Delivery Systems Explanation: **Explanation:**
**Pilocarpine** is a direct-acting parasympathomimetic (cholinergic agonist) that acts on the muscarinic receptors (M3) of the iris sphincter muscle and the ciliary body.
**Why it is the drug of choice for Acute Angle Closure Glaucoma (AACG):**
In AACG, the primary goal is to pull the peripheral iris away from the trabecular meshwork to open the drainage angle. Pilocarpine causes **miosis** (pupillary constriction), which physically stretches the iris, thinning it and pulling it out of the angle. This restores the outflow of aqueous humor and rapidly lowers intraocular pressure (IOP).
*Note:* In clinical practice, it is typically administered once the IOP has been slightly lowered by systemic agents (like Acetazolamide), as the iris sphincter is often ischemic and non-responsive when IOP is >40-50 mmHg.
**Why other options are incorrect:**
* **Open Angle Glaucoma:** While Pilocarpine can lower IOP by increasing trabecular outflow, it is no longer a first-line treatment due to side effects like miosis (causing night blindness) and accommodative spasms (brow ache). Prostaglandin analogues and Beta-blockers are preferred.
* **Pigmentary Glaucoma:** This is a subtype of open-angle glaucoma. While miotics can reduce iris-zonule friction, they are rarely the "drug of choice" compared to modern medical or laser therapies.
**High-Yield Clinical Pearls for NEET-PG:**
1. **Mechanism in AACG:** Miosis → Mechanical opening of the angle.
2. **Side Effects:** Accommodative spasm (pseudomyopia), brow ache, and retinal detachment (due to ciliary body contraction pulling on the retina).
3. **Contraindication:** It should **never** be used in **Uveitic Glaucoma** or Malignant Glaucoma, as it can worsen inflammation and promote posterior synechiae formation.
4. **Pre-Laser:** It is routinely used before Peripheral Iridotomy (LPI) to thin the iris, making the procedure easier.
More Novel Drug Delivery Systems Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
